Literature DB >> 8373375

Co-expression of collagens II and XI and alternative splicing of exon 2 of collagen II in several developing human tissues.

M M Sandberg1, H E Hirvonen, K J Elima, E I Vuorio.   

Abstract

Northern analyses, RNAase protection assays and in situ hybridizations were used to study the expression of the mRNA for the alpha 2 chain of collagen XI and the two different mRNAs generated from the collagen II gene through alternative splicing of exon 2 in several different tissues of 15-19-week-old fetuses. The highest expression levels of procollagen alpha 2(XI) and alpha 1(II) mRNAs were detected in cartilage, but, using long exposure times, Northern hybridization revealed the presence of the approximately 5.3 kb procollagen alpha 1(II) mRNA in most tissues analysed: calvarial and diaphyseal bone, striated and cardiac muscle, skin, brain, lung, kidney, liver, small intestine and colon. Both alternatively spliced forms of the mRNA were present in these tissues. In cartilage, the short form of the procollagen alpha 1(II) mRNA (without exon 2 sequences) was clearly more abundant, whereas in most of the non-cartilaginous tissues the long form was the predominant one. Low levels of procollagen alpha 2(XI) mRNA were also seen in non-cartilaginous tissues: calvarial and diaphyseal bone, kidney, skin, muscle, intestine, liver, brain, and lung. In all the other positive tissues except brain cortex, both collagen II and XI transcripts were observed. The localization of collagen II and XI signals was identical in cartilage, kidney and skin. However, in cartilage the signal with collagen II probe was much higher than that with the collagen alpha 2(XI) probe. In epidermis the situation was reversed. Our results show considerable co-expression and co-localization of procollagen alpha 1(II) and alpha 2(XI) mRNAs in many tissues of developing human fetuses. Since the collagen alpha 1(II) gene also codes for the alpha 3(XI) chain of collagen XI we propose that some, but not all, of the expression of the collagen II gene in non-cartilaginous tissues relates to collagen XI production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373375      PMCID: PMC1134497          DOI: 10.1042/bj2940595

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Collagen heterogeneity in human cartilage: identification of several new collagen chains.

Authors:  R E Burgeson; D W Hollister
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

2.  Inhibiting effect of procollagen peptides on collagen biosynthesis in fibroblast cultures.

Authors:  M Wiestner; T Krieg; D Hörlein; R W Glanville; P Fietzek; P K Müller
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

3.  Are collagen fibrils in the developing avian cornea composed of two different collagen types? Evidence from monoclonal antibody studies.

Authors:  T F Linsenmayer; J M Fitch; J Gross; R Mayne
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Identification and characterization of the human type II collagen gene (COL2A1).

Authors:  K S Cheah; N G Stoker; J R Griffin; F G Grosveld; E Solomon
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Transient expression of collagen type II at epitheliomesenchymal interfaces during morphogenesis of the cartilaginous neurocranium.

Authors:  P Thorogood; J Bee; K von der Mark
Journal:  Dev Biol       Date:  1986-08       Impact factor: 3.582

6.  Different levels of glycosylation contribute to the heterogeneity of alpha 1(II) collagen chains derived from a transplantable rat chondrosarcoma.

Authors:  D K Furuto; E J Miller
Journal:  Arch Biochem Biophys       Date:  1983-10-15       Impact factor: 4.013

7.  Isolation and characterization of genomic clones corresponding to the human type II procollagen gene.

Authors:  C M Strom; W B Upholt
Journal:  Nucleic Acids Res       Date:  1984-01-25       Impact factor: 16.971

8.  Evidence for pretranslational regulation of collagen synthesis by procollagen propeptides.

Authors:  C H Wu; C B Donovan; G Y Wu
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

9.  Construction and identification of a cDNA clone for human type II procollagen mRNA.

Authors:  K Elima; J K Mäkelä; T Vuorio; S Kauppinen; J Knowles; E Vuorio
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

10.  Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin.

Authors:  R Fleischmajer; R Timpl; L Tuderman; L Raisher; M Wiestner; J S Perlish; P N Graves
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

View more
  7 in total

1.  Expression patterns of cartilage collagens and Sox9 during mouse heart development.

Authors:  Otto Rahkonen; Mikko Savontaus; Eltyeb Abdelwahid; Eero Vuorio; Eero Jokinen
Journal:  Histochem Cell Biol       Date:  2003-07-18       Impact factor: 4.304

Review 2.  Predictors of recurrence in the management of chordoid meningioma.

Authors:  Winward Choy; Leonel Ampie; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  J Neurooncol       Date:  2015-09-26       Impact factor: 4.130

3.  Immunohistochemical localization of collagen type XI alpha1 and alpha2 chains in human colon tissue.

Authors:  Kara B Bowen; Aaron P Reimers; Sarah Luman; Joseph D Kronz; William E Fyffe; Julia Thom Oxford
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

Review 4.  Extracellular matrix components in intestinal development.

Authors:  P Simon-Assmann; M Kedinger; A De Arcangelis; V Rousseau; P Simo
Journal:  Experientia       Date:  1995-09-29

5.  The mRNAs for the three chains of human collagen type XI are widely distributed but not necessarily co-expressed: implications for homotrimeric, heterotrimeric and heterotypic collagen molecules.

Authors:  V C Lui; R Y Kong; J Nicholls; A N Cheung; K S Cheah
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

6.  COL11A1 in FAP polyps and in sporadic colorectal tumors.

Authors:  H Fischer; S Salahshor; R Stenling; J Björk; G Lindmark; L Iselius; C Rubio; A Lindblom
Journal:  BMC Cancer       Date:  2001-10-29       Impact factor: 4.430

7.  Col11a1 Regulates Bone Microarchitecture during Embryonic Development.

Authors:  Anthony Hafez; Ryan Squires; Amber Pedracini; Alark Joshi; Robert E Seegmiller; Julia Thom Oxford
Journal:  J Dev Biol       Date:  2015-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.